Surya Pharmaceutical Ltd.
| BSE: 532516 | Sector: Health care |
| NSE: SURYAPHARM | ISIN Code: INE249G01020 |
| BSE 00:00 | 24 Feb | Surya Pharmaceutical Ltd |
| NSE 05:30 | 01 Jan | Surya Pharmaceutical Ltd |
| OPEN | 0.22 |
| PREVIOUS CLOSE | 0.22 |
| VOLUME | 241733 |
| 52-Week high | 0.23 |
| 52-Week low | 0.00 |
| P/E | 0.02 |
| Mkt Cap.(Rs cr) | 4 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.23 |
| Sell Qty | 1.00 |
Surya Pharmaceutical Ltd. (SURYAPHARM) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Cipla | 939.60 | 12.35 | 1.33 | 13900.58 |
| Dr Reddy's Labs | 4771.30 | 50.10 | 1.06 | 13349.10 |
| Aurobindo Pharma | 906.05 | -11.15 | -1.22 | 13266.48 |
| Sun Pharma.Inds. | 785.65 | -9.20 | -1.16 | 12531.93 |
| Lupin | 1152.30 | 8.85 | 0.77 | 11055.93 |
| Apollo Hospitals | 4067.30 | -24.65 | -0.60 | 9794.50 |
| Cadila Health. | 587.85 | -4.10 | -0.69 | 7790.40 |
| Alkem Lab | 3379.90 | -129.80 | -3.70 | 7219.68 |
| Divi's Lab. | 4966.35 | -41.60 | -0.83 | 6798.61 |
| Glenmark Pharma. | 596.10 | -8.10 | -1.34 | 6712.63 |
| Torrent Pharma. | 3075.20 | -27.30 | -0.88 | 6450.83 |
| Alembic Pharma | 786.40 | 0.55 | 0.07 | 5051.44 |
| Laurus Labs | 646.40 | -1.00 | -0.15 | 4768.72 |
| Ipca Labs. | 2087.55 | -7.85 | -0.37 | 4337.82 |
| Abbott India | 18038.95 | -1210.80 | -6.29 | 4310.02 |
| Glaxosmi. Pharma | 1689.50 | 6.75 | 0.40 | 3193.74 |
| Jubilant Pharmo | 663.45 | -15.95 | -2.35 | 3139.90 |
| Granules India | 386.70 | 4.50 | 1.18 | 3134.98 |
| Sanofi India | 8589.40 | 13.00 | 0.15 | 2901.90 |
| Ajanta Pharma | 2288.45 | 25.50 | 1.13 | 2718.59 |
Quick Links for Surya Pharmaceutical:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
